Mediastinum, Pleura, Lung Tumors

Neutron therapy is appropriate for the following histologies:

  • Adenocarcinoma
  • Fibrosarcoma
  • Liposarcoma
  • Mesothelioma
  • Soft tissue sarcoma
Patients who may benefit from neutron therapy include:
  • Newly diagnosed patients with unresectable (inoperable) disease, or residual disease following surgery (positive margins).
  • Patients whose disease has recurred after surgery.



For general questions please contact neutrons@fnal.gov   For web questions, email kroc@fnal.gov   Or call 630-840-3865
Security, Privacy, LegalFermi National Accelerator Laboratory

Security, Privacy, Legal